Hostname: page-component-5db58dd55d-f6s65 Total loading time: 0 Render date: 2026-05-25T10:02:45.943Z Has data issue: false hasContentIssue false
  • English
  • Français

Inclusion body myositis and dysphagia. Presentation, intervention and outcome at a swallowing clinic

Published online by Cambridge University Press:  02 March 2022

M Shrivastava Open the ORCID record for M Shrivastava [Opens in a new window] ,
C Harris ,
S Holmes ,
S Brady  and
S Winter
M Shrivastava*
Affiliation:
ENT Department, Oxford University Foundation Trust, Oxford, United Kingdom
C Harris
Affiliation:
ENT Department, Oxford University Foundation Trust, Oxford, United Kingdom
S Holmes
Affiliation:
ENT Department, Oxford University Foundation Trust, Oxford, United Kingdom
S Brady
Affiliation:
Nuffield Department of Clinical Neurosciences, Oxford University Hospitals, Oxford, UK
S Winter
Affiliation:
ENT Department, Oxford University Foundation Trust, Oxford, United Kingdom
*
Author for correspondence: Dr M Shrivastava, ENT Department, Oxford University Foundation Trust, Headley Way, Oxford OX3 9DU, UK E-mail: manu.shrivastava1@nhs.net
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

This study reviewed patients with inclusion body myositis who were referred for assessment of dysphagia at a tertiary swallow clinic. It describes symptoms at presentation, imaging and management strategies.

Method

A retrospective review of electronic patient records was performed between 2016 and 2020.

Results

Twenty-four patients were included, with a mean age of 72 years. Baseline modified Sydney Swallow Questionnaires identified problems with hard or dry food, food sticking, and repeated swallowing. Twenty-two patients had a Reflux Symptom Index score that could indicate significant reflux. Video swallow identified specific problems, including tongue base retraction (96 per cent) and residual pharyngeal pooling (92 per cent). Seven patients (30 per cent) had features of aspiration on imaging despite a median penetration-aspiration scale score of 2. Four patients received balloon dilatation, and two patients underwent cricopharyngeal myotomy.

Conclusion

This study helped to profile features of dysphagia in patients with inclusion body myositis. More evidence is needed to determine the most effective management pathway for these patients.

Keywords

DysphagiaInclusion Body MyositisDeglutition DisordersNeuromuscular Diseases

Information

Type
Main Article
Information
The Journal of Laryngology & Otology , Volume 137 , Issue 2 , February 2023 , pp. 213 - 218
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Dr M Shrivastava takes responsibility for the integrity of the content of the paper

References

Meyer, A, Meyer, N, Schaeffer, M, Gottenberg, JE, Geny, B, Sibilia, J. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology (Oxford) 2015;54:50–63CrossRefGoogle ScholarPubMed
Dimachkie, MM, Barohn, RJ. Inclusion body myositis. Semin Neurol 2012;32:237–45Google ScholarPubMed
Cox, FM, Titulaer, MJ, Sont, JK, Wintzen, AR, Verschuuren, JJ, Badrising, UA. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain 2011;134:3167–7510.1093/brain/awr217CrossRefGoogle ScholarPubMed
Price, MA, Barghout, V, Benveniste, O, Christopher-Stine, L, Corbett, A, de Visser, M et al. Mortality and causes of death in patients with sporadic inclusion body myositis: survey study based on the clinical experience of specialists in Australia, Europe and the USA. J Neuromuscul Dis 2016;3:67–75CrossRefGoogle ScholarPubMed
Houser, SM, Calabrese, LH, Strome, M. Dysphagia in patients with inclusion body myositis. Laryngoscope 1998;108:1001–5CrossRefGoogle ScholarPubMed
Mohannak, N, Pattison, G, Hird, K, Needham, M. Dysphagia in patients with sporadic inclusion body myositis: management challenges. Int J Gen Med 2019;12:465–74CrossRefGoogle ScholarPubMed
Mulcahy, KP, Langdon, PC, Mastaglia, F. Dysphagia in inflammatory myopathy: self-report, incidence, and prevalence. Dysphagia 2012;27:64–9CrossRefGoogle ScholarPubMed
Cox, FM, Verschuuren, JJ, Verbist, BM, Niks, EH, Wintzen, AR, Badrising, UA. Detecting dysphagia in inclusion body myositis. J Neurol 2009;256:2009–13CrossRefGoogle ScholarPubMed
Murata, KY, Kouda, K, Tajima, F, Kondo, T. A dysphagia study in patients with sporadic inclusion body myositis (s-inclusion body myositis). Neurol Sci 2012;33:765–70CrossRefGoogle Scholar
Schrey, A, Airas, L, Jokela, M, Pulkkinen, J. Botulinum toxin alleviates dysphagia of patients with inclusion body myositis. J Neurol Sci 2017;380:142–710.1016/j.jns.2017.07.031CrossRefGoogle ScholarPubMed
Ekberg, O, Hamdy, S, Woisard, V, Wuttge-Hannig, A, Ortega, P. Social and psychological burden of dysphagia: its impact on diagnosis and treatment. Dysphagia 2002;17:139–46CrossRefGoogle ScholarPubMed
Capkun, G, Schmidt, J, Ghosh, S, Sharma, H, Obadia, T, de Vera, A et al. Development and validation of a Bayesian survival model for inclusion body myositis. Theor Biol Med Model 2019;16:17CrossRefGoogle ScholarPubMed
Oh, TH, Brumfield, KA, Hoskin, TL, Kasperbauer, JL, Basford, JR. Dysphagia in inclusion body myositis: clinical features, management, and clinical outcome. Am J Phys Med Rehabil 2008;87:883–9CrossRefGoogle ScholarPubMed
Rosenbek, JC, Robbins, JA, Roecker, EB, Coyle, JL, Wood, JL. A penetration-aspiration scale. Dysphagia 1996;11:93–8CrossRefGoogle ScholarPubMed
Phillips, BA, Zilko, PJ, Mastaglia, FL. Prevalence of sporadic inclusion body myositis in Western Australia. Muscle Nerve 2000;23:970–23.0.CO;2-I>CrossRefGoogle ScholarPubMed
Badrising, UA, Maat-Schieman, ML, van Houwelingen, JC, van Doorn, PA, van Duinen, SG, van Engelen, BG et al. Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients. J Neurol 2005;252:1448–54CrossRefGoogle ScholarPubMed
Lotz, BP, Engel, AG, Nishino, H, Stevens, JC, Litchy, WJ. Inclusion body myositis. Observations in 40 patients. Brain 1989;112:727–47CrossRefGoogle ScholarPubMed
Shibata, S, Izumi, R, Hara, T, Ohshima, R, Nakamura, N, Suzuki, N et al. Five-year history of dysphagia as a sole initial symptom in inclusion body myositis. J Neurol Sci 2017;381:325–7CrossRefGoogle ScholarPubMed
Liu, LW, Tarnopolsky, M, Armstrong, D. Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. Can J Gastroenterol 2004;18:397–9CrossRefGoogle Scholar
Langdon, PC, Mulcahy, K, Shepherd, KL, Low, VH, Mastaglia, FL. Pharyngeal dysphagia in inflammatory muscle diseases resulting from impaired suprahyoid musculature. Dysphagia 2012;27:408–17CrossRefGoogle ScholarPubMed
McMillan, RA, Bowen, AJ, Bayan, SL, Kasperbauer, JL, Ekbom, DC. Cricopharyngeal myotomy in inclusion body myositis: comparison of endoscopic and transcervical approaches. Laryngoscope 2021;131:E2426–31Google ScholarPubMed
Martin-Harris, B, Brodsky, MB, Michel, Y, Castell, DO, Schleicher, M, Sandidge, J et al. MBS measurement tool for swallow impairment--MBSImp: establishing a standard. Dysphagia 2008;23:392–405CrossRefGoogle ScholarPubMed
Steele, CM, Grace-Martin, K. Reflections on clinical and statistical use of the penetration-aspiration scale. Dysphagia 2017;32:601–16CrossRefGoogle ScholarPubMed
Hutcheson, KA, Barrow, MP, Barringer, DA, Knott, JK, Lin, HY, Weber, RS et al. Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): scale development and validation. Cancer 2017;123:62–70CrossRefGoogle ScholarPubMed
Supplementary material: Image

Shrivastava et al. supplementary material

Shrivastava et al. supplementary material

Download Shrivastava et al. supplementary material(Image)
Image 143.1 KB